Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Toyoaki Hida
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
EGFR Exon 19 Insertions Show Good Response to Gefitinib, but Short Time to Progression in Japanese Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Unique Prevalence of Oncogenic Genetic Alterations in Young Patients With Lung Adenocarcinoma
Cancer
Cancer Research
Oncology
Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib
ESMO Open
Cancer Research
Oncology
Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Three‐year Follow‐up Results From Phase II Studies of Nivolumab in Japanese Patients With Previously Treated Advanced Non‐small Cell Lung Cancer: Pooled Analysis of ONO‐4538‐05 and ONO‐4538‐06 Studies
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma
PLoS ONE
Multidisciplinary
Importance of Avoiding Surgery Delays After Initial Discovery of Suspected Non-Small-Cell Lung Cancer in Clinical Stage IA Patients
Cancer Management and Research
Oncology
hOGG1 Ser326Cys Polymorphism and Risk of Lung Cancer by Histological Type
Journal of Human Genetics
Genetics
